SCHEMBL2225385

SCHEMBL2225385

CSc1ccc(S(N)(=O)=O)cc1CNc1cc(Nc2ccc3c(c2)OCCO3)ncn1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CDK1 P06493 1/20 0.43
CCNB1 P14635 1/20 0.43
CCNA2 P20248 1/20 0.43
CCNE1 P24864 1/20 0.43
CDK2 P24941 1/20 0.43
CDK5 Q00535 1/20 0.43
CDK5R1 Q15078 1/20 0.43
TRPV1 Q8NER1 2/20 0.41
BACE1 P56817 1/20 0.41
ALDH1A1 P00352 4/20 0.41
LMNA P02545 4/20 0.41
SMN1; SMN2 Q16637 2/20 0.41
EGFR P00533 2/20 0.41
ERBB3 P21860 2/20 0.41
TNNI3K Q59H18 1/20 0.40
MAPT P10636 5/20 0.39
PKM P14618 1/20 0.39
ALOX15 P16050 1/20 0.39
TSHR P16473 1/20 0.39
HTT P42858 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2228558 0.95 CDK2 (0.43) CDK1CCNB1CCNA2CCNE1CDK2
SCHEMBL2227241 0.83 CDK1 (0.46) CDK1CCNB1CCNA2CCNE1CDK2
SCHEMBL2227638 0.83 TNNI3K (0.57) CDK1CCNB1CCNA2CCNE1CDK2
SCHEMBL2226860 0.82 TNNI3K (0.45) CDK1CCNB1CCNA2CCNE1CDK2
SCHEMBL2226143 0.81 CCNA2 (0.47) CDK1CCNB1CCNA2CCNE1CDK2
SCHEMBL2225639 0.81 EGFR (0.44) CDK1CCNB1CCNA2CCNE1CDK2
SCHEMBL2226099 0.80 IRAK4 (0.44) CDK1CCNB1CCNA2CCNE1CDK2
SCHEMBL2224279 0.80 EGFR (0.53) CDK1CCNB1CCNA2CCNE1CDK2
SCHEMBL2226407 0.79 TNNI3K (0.42) CDK1CCNB1CCNA2CCNE1CDK2
SCHEMBL2224234 0.79 TNNI3K (0.43) CDK1CCNB1CCNA2CCNE1CDK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2523559-A1 COMPOUNDS AND METHODS GlaxoSmithKline LLC (US) 2012-11-21 EP claimed
WO-2011088027-A1 COMPOUNDS AND METHODS GLAXOSMITHKLINE LLC (US) 2011-07-21 WO claimed
EP-2523559-A1 COMPOUNDS AND METHODS GlaxoSmithKline LLC (US) 2012-11-21 EP disclosed
WO-2011088027-A1 COMPOUNDS AND METHODS GLAXOSMITHKLINE LLC (US) 2011-07-21 WO disclosed